Falling prescription drug prices are driven by fierce GLP-1 market competition, not by White House policies or government portals.

Falling prescription drug prices are driven by fierce GLP-1 market competition, not by White House policies or government portals.

Trump delivered historic drops in prescription drug prices, but Congress must rein in PBM middlemen to make those savings last.